The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

Nanomedicine has emerged as a novel cancer treatment and diagnostic modality, whose design constantly evolves towards increasing the safety and efficacy of the chemotherapeutic and diagnostic protocols. Molecular diagnostics, which create a great amount of data related to the unique molecular signat...

Descripción completa

Detalles Bibliográficos
Autores principales: Geskovski, Nikola, Matevska-Geshkovska, Nadica, Dimchevska Sazdovska, Simona, Glavas Dodov, Marija, Mladenovska, Kristina, Goracinova, Katerina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093552/
https://www.ncbi.nlm.nih.gov/pubmed/33981532
http://dx.doi.org/10.3762/bjnano.12.31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093552/
https://www.ncbi.nlm.nih.gov/pubmed/33981532
http://dx.doi.org/10.3762/bjnano.12.31

Ejemplares similares